Clinical Trials Browser

Phase 2 × OTHER × Anti-N-Methyl-D-Aspartate Receptor Encephalitis × Clear all

NCT06510283 2024-11-20

Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis

Phase 2 Recruiting

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

NCT03274375 2023-07-13

IANMDAR

Phase 2 Recruiting

Anti-N-Methyl-D-Aspartate Receptor Encephalitis